Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity
about
Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeA mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindredsThe surfactant peptide KL4 in lipid monolayers: phase behavior, topography, and chemical distributionRegulation of messenger RNAs for the hydrophobic surfactant proteins in human lungSurfactant for pediatric acute lung injurySurfactant therapy for acute lung injury and acute respiratory distress syndrome.Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthmaDynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lungTargeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice.Effect of hydrophobic surfactant proteins SP-B and SP-C on binary phospholipid monolayers: II. Infrared external reflectance-absorption spectroscopy.Content-dependent activity of lung surfactant protein B in mixtures with lipids.Identification of a cell membrane protein that binds alveolar surfactantThe helical structure of surfactant peptide KL4 when bound to POPC: POPG lipid vesicles.Pharmacotherapy of acute lung injury and acute respiratory distress syndromeIntraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth.Function and regulation of expression of pulmonary surfactant-associated proteins.A proposed nomenclature for pulmonary surfactant-associated proteins.Effects of a cationic and hydrophobic peptide, KL4, on model lung surfactant lipid monolayers.Molecular mobility in the monolayers of foam films stabilized by porcine lung surfactant.Hormonal effects on the surfactant protein B (SP-B) mRNA in cultured fetal rat lung.The effect of a C-terminal peptide of surfactant protein B (SP-B) on oriented lipid bilayers, characterized by solid-state 2H- and 31P-NMR.Exogenous surfactant for the respiratory distress syndromeAntigenicity of low molecular weight surfactant species.Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant.Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.Distinct effects of SP-B and SP-C on the uptake of surfactant-like liposomes by alveolar cells in vivo and in vitro.Mikko Hallman --a major translator of basic science into neonatal medicine.Treatment responses to surfactants containing natural surfactant proteins in preterm rabbits.
P2860
Q24240106-17367B76-EC02-4EBD-A7B1-E2C78AF14D8AQ24243198-9D799398-CE93-44C6-BEC5-4B420BCE3E7DQ24244224-605B584F-2B5E-4EEB-AE9B-F18C2572DD41Q24605337-F9483A99-76DC-40B1-82DA-9BCDE29890C7Q28261677-35B89AC1-AB39-420A-A2EC-F9DB30CC9F36Q28342391-BBBEDDCC-1379-44D2-BE09-971F96B1CFDDQ30409008-75B4C8AE-1D9F-48F5-AE56-BF9278FCF437Q30426177-F8C92C36-A725-4B72-AFCF-4CCEADB3324CQ33284455-3E0FB6EB-2839-415A-A14D-5B4AD1E50E2AQ33302898-4F1E0F8A-6523-463B-B458-F3CDE59B4664Q33679826-F5F8C235-FF4F-43CD-AA43-EF2086F85009Q34008084-245A9B1A-B7B4-48FB-B374-F30294D520E2Q34180142-55C854B6-4754-4510-9E97-383E662A5549Q34958845-56F899D0-4471-44C9-B298-71D7C97A96FDQ35830285-9D6413B6-9225-4ECA-B3F2-DE29495D068DQ37069359-36C96744-C71D-4774-B14B-FA4E9AEC22EDQ37085611-822E179D-560F-4A66-BFD9-640C4C23BA47Q37369026-26268597-928C-4070-9890-41D10020AEDDQ37632052-0D62F92C-918C-4F84-A5C8-372419F047B3Q39548005-4DAD76DE-A6BD-4A29-AC0E-6E8159200C26Q40118703-58295873-9743-4EA7-8301-FF624C71008AQ41773933-3D7C8B00-E7F3-4BDE-8DBA-819479C192BBQ41830593-5282351A-91FC-4029-BA3A-54625AD38EF7Q41836928-A09642A9-3B3A-46C9-8FE1-3F7BD0AFE7C3Q42580195-2CC6E951-DCBD-426C-B2BD-5706A36929C1Q42769723-D9421B8B-1556-4374-904D-FFD4FFD4AC2CQ44832470-C8057745-C346-42DA-B8A0-C9E89A36BE88Q45973628-1AAD3491-7734-4005-AA0C-F36ADBB9BBB2Q47955071-6DCA407C-718C-44EF-86E1-A1A1EADDCAD0Q48433880-D4D1FDD4-25AF-4A0A-96DE-AD050CAC85C1Q54051123-790B7EAB-1766-4B8B-9CB8-44C71C26FC73
P2860
Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity
description
1988 nî lūn-bûn
@nan
1988 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մարտին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Use of human surfactant low mo ...... f surfactant biologic activity
@ast
Use of human surfactant low mo ...... f surfactant biologic activity
@en
Use of human surfactant low mo ...... f surfactant biologic activity
@nl
type
label
Use of human surfactant low mo ...... f surfactant biologic activity
@ast
Use of human surfactant low mo ...... f surfactant biologic activity
@en
Use of human surfactant low mo ...... f surfactant biologic activity
@nl
prefLabel
Use of human surfactant low mo ...... f surfactant biologic activity
@ast
Use of human surfactant low mo ...... f surfactant biologic activity
@en
Use of human surfactant low mo ...... f surfactant biologic activity
@nl
P2093
P2860
P356
P1476
Use of human surfactant low mo ...... f surfactant biologic activity
@en
P2093
C G Cochrane
M Courtney
T A Merritt
P2860
P304
P356
10.1172/JCI113391
P407
P577
1988-03-01T00:00:00Z